Urman, Robert
Princic, Nicole
Vuvu, Fiston
Patel, Leah B.
Oh, Sam
Chandler, David
Hindiyeh, Nada
Bensink, Mark E.
Funding for this research was provided by:
Amgen
Article History
Received: 4 June 2024
Accepted: 8 August 2024
First Online: 23 August 2024
Declarations
:
: Robert Urman, Fiston Vuvu, Leah B. Patel, Sam Oh, and David Chandler are or were employed by Amgen Inc. at the time of the study. Nicole Princic is employed by Merative, which received funding from Amgen Inc. to conduct this study. Nada Hindiyeh and Mark E. Bensink are paid consultants of Amgen Inc. This research was presented in part at the 2023 American Headache Society 65th Annual Scientific Meeting in Austin, Texas.
: All database records are statistically de-identified and certified to be fully compliant with US patient confidentiality requirements set forth in the Health Insurance Portability and Accountability Act of 1996. Because this study used only de-identified patient records and did not involve the collection, use, or transmittal of individually identifiable data, this study was exempted from institutional review board approval.